January 21, 2026 C-Path’s Translational Therapeutics Accelerator Announces 2026 Request for Proposals from Academic Investigators TUCSON, Ariz., January 21, 2026 — Critical Path Institute’s® (C-Path) Translational Therapeutics Accelerator today...
January 13, 2026 20 Years of Innovation: Reflecting on C-Path’s Legacy and Looking Ahead, Pt. 2 C-Path's newest podcast episode picks up on the 20th Anniversary commemoration and provides an insight...
December 17, 2025 The Critical Path Institute Podcast: 20 Years of Impact Reflect on C-Path’s Legacy and a Look Ahead, Pt. 1 This C-Path podcast episode celebrates C-Path's 20 years of impactful innovation, and looks at the future of...
December 12, 2025 View Now: Biomarker Data Repository Workshop December 2025 First workshop in a series on the Biomarker Data Repository (BmDR). This inaugural workshop will feature presentations on BmDR...
December 12, 2025 Emerging Therapies in Autosomal Dominant Polycystic Kidney Disease Autosomal dominant polycystic kidney disease (ADPKD) is the most...
December 11, 2025 Recording Available: From Vision to Reality — 6 Years of RDCA-DAP, Driving Drug Development Solutions and Innovations in Data Sharing This session will demonstrate how data sharing can move mountains for rare disease research — with real-world examples...
December 5, 2025 Rare/Orphan and Pediatric Disease Programs: Quarterly Newsletter December 2025 Welcome to the Rare/Orphan and Pediatric Disease Programs quarterly newsletter. In between major announcements...
December 3, 2025 Rare Disease COA Consortium Publication on Study Designs and Crafting Endpoints for Gene Therapy Development Programs in Rare Disease C-Path’s Rare Disease COA Consortium is delighted to share that “Study Designs and Crafting Endpoints...
December 1, 2025 C-Path Rare/0rphan and Pediatric Disease Programs Q4 2025 Newsletter Now Available Welcome to the Rare/Orphan and Pediatric Disease Programs quarterly newsletter. In between major announcements, webinars...
